Previously, it has been revealed that 93% of detected mutations in FH patients are located in LDLR gene, whereas the APOB variant (R3500Q) and PCSK9 mutation account for approximately 5% and 1.7% of FH patients[5]. This evidence concerns the gene APOB and familial hyperaldosteronism.